🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the immunogenicity and safety of G...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-12-15
Trial ID
NCT02581410
Treatments Being Tested
The purpose of this study was a long-term follow-up of the two studies 1103...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-04-16
Trial ID
NCT02723773
Treatments Being Tested
The purpose of this study was to assess the safety and immunogenicity of GS...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-09-17
Trial ID
NCT04091451
Treatments Being Tested
The purpose of this observer-blind study is to evaluate the efficacy, safet...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-08-02
Trial ID
NCT01165177
Treatments Being Tested
The purpose of this study is to cross-vaccinate and collect safety data in ...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-03-16
Trial ID
NCT02690207
Treatments Being Tested
The safety and immunogenicity of the GSK324332A vaccine has been evaluated ...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-06-25
Trial ID
NCT00492648
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity and safety of G...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-06-10
Trial ID
NCT01827839
Treatments Being Tested
The purpose of this observer-blind study is to evaluate the safety and immu...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-07-14
Trial ID
NCT00920218
Treatments Being Tested
The purpose of this study is to demonstrate lot-to-lot consistency in terms...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-08-13
Trial ID
NCT02075515
Treatments Being Tested
The purpose of this study is to assess the immunogenicity, safety, and reac...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-06-17
Trial ID
NCT01777321
Treatments Being Tested